X-Ray Diffraction (XRD) Instrument

Closed Solicitation Posted

Solicitation number
FDA-19-RFQ-1214636
Agency
FDA Office of Acquisition and Grant Services Food and Drug Administration, Department of Health and Human Services
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

The U.S. Food and Drug Administration's Center for Drug Evaluation (CDER), Division of Pharmaceutical Analysis has a requirement for to acquire XRD systems to perform testing and research on characterizing opioid drug products and other pharmaceuticals.

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; quotes are being requested, and a separate written solicitation will not be issued.


This solicitation is a Request for Quote (RFQ) using FAR Parts 12 and 13.5 procedures. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2019-03. The North American Industry Classification System (NAICS) code for the proposed acquisition is 334516, Analytical Laboratory Instrument Manufacturing.



For full description/details please refer to attached document "FDA-19-RFQ-1214636.pdf"

.

Attachments

Files attached to this notice, newest first
File Type Posted
FDA-19-RFQ-1214636.pdf PDF

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity